EVO756 Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
Atoptic Dermatitis
Evommune, Inc.120 enrolled29 locationsNCT07150845
Recruiting
Phase 2
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
Chronic Spontaneous Urticaria
Evommune, Inc.160 enrolled53 locationsNCT06873516